StockData
Neuphoria Therapeutics Inc. logo

Neuphoria Therapeutics Inc. (NEUP) stock

NEUPNasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-K on Sep 18, 2026Score 5/30
$2.48−0.07 (-2.75%)

Close on Nov 16, 2026Market cap $74.56KP/E –Yield –

Neuphoria Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

For fiscal 2026 it was -1145.7%, against -2.4% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2026Jun 30, 2026-1145.7%−1143.3
FY2025Jun 30, 2025-2.4%–

Quarterly profit margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q3 FY2025CQ1 2025Mar 31, 202575.1%–
Q2 FY2025CQ4 2024Dec 31, 2024-293.2%–

More Neuphoria Therapeutics figures

See a number that looks wrong?